Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
PaperCitations, authors & open-access status
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 467 citations, 2011 year and closed oa status.
467
Citations
2011
Year
closed
OA Status